Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Resonance Health Ltd (RHT.AX)

Resonance Health Ltd (RHT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Resonance Health Ltd 141 Burswood Road Level 1 Burswood WA 6100 AUS

https://www.resonancehealth.com P: +61 892865300 F: +61 892865399

Description:

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

Key Statistics

Overview:

Market Capitalization, $K 35,751
Shares Outstanding, K 446,893
Annual Sales, $ 4,404 K
Annual Net Income, $ -780 K
% of Institutional Shareholders 0.26%

Growth:

1-Year Return 81.82%
3-Year Return -57.89%
5-Year Return -38.46%
5-Year Revenue Growth 8.74%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.00
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/15/03

RHT.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -10.73%
Return-on-Assets % -9.61%
Profit Margin % -17.72%
Debt/Equity 0.02
Price/Sales 6.34
Price/Book 3.63
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar